WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005113541) PYRROLE COMPOUNDS AS INHIBITORS OF ERK PROTEIN KINASE, SYNTHESIS THEREOF AND INTERMEDIATES THERETO
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/113541    International Application No.:    PCT/US2005/016902
Publication Date: 01.12.2005 International Filing Date: 13.05.2005
IPC:
C07D 401/04 (2006.01), C07F 9/58 (2006.01), A61K 31/4439 (2006.01), A61P 9/00 (2006.01), A61P 25/00 (2006.01), A61P 37/00 (2006.01)
Applicants: VERTEX PHARMACEUTICALS, INCORPORATED [US/US]; 130 Waverly Street, Cambridge, MA 02139 (US) (For All Designated States Except US).
MARTINEZ-BOTELLA, Gabriel [ES/US]; (US) (For US Only).
HALE, Michael, R. [US/US]; (US) (For US Only).
MALTAIS, François [CA/US]; (US) (For US Only).
TANG, Qing [CN/US]; (US) (For US Only).
STRAUB, Judith [US/US]; (US) (For US Only)
Inventors: MARTINEZ-BOTELLA, Gabriel; (US).
HALE, Michael, R.; (US).
MALTAIS, François; (US).
TANG, Qing; (US).
STRAUB, Judith; (US)
Agent: ROBIDOUX, Andrea, L., C.; Patent Group, Choate, Hall & Stewart LLP, Two International Place, Boston, MA 02110 (US)
Priority Data:
60/571,309 14.05.2004 US
  13.05.2005 US (Considered void 19.10.2005)
Title (EN) PYRROLE COMPOUNDS AS INHIBITORS OF ERK PROTEIN KINASE, SYNTHESIS THEREOF AND INTERMEDIATES THERETO
(FR) COMPOSES PYRROLES UTILISES EN TANT QU'INHIBITEURS DE PROTEINES KINASES ERK, LEUR SYNTHESE, ET INTERMEDIAIRES CORRESPONDANTS
Abstract: front page image
(EN)The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
(FR)L'invention concerne des composés servant à inhiber des protéines kinases. Cette invention se rapporte en outre à des compositions pharmaceutiquement acceptables comportant lesdits composés, ainsi qu'à des procédés pour utiliser lesdites compositions pour traiter différentes maladies ainsi que divers états et troubles.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)